# NextCure, Inc.: Form 8-K, filed Jun 16, 2025

- Company: [NextCure, Inc.](/companies/nxtc.md) (CIK 1661059)
- Form: 8-K
- Filed: 2025-06-16
- Accepted by EDGAR: Jun 16, 2025, 07:15 ET
- Period: 2025-06-13
- Accession: 0001558370-25-008633
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1661059/000155837025008633/nxtc-20250613x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1661059/000155837025008633/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1661059/000155837025008633/nxtc-20250613x8k.htm

Filed Jun 16, 2025.
Source: SEC EDGAR, the filing index for accession 0001558370-25-008633. Last ingested by Listed: Nov 2, 2026, 06:06 ET. No prices; not investment advice.